This paper is in the following e-collection/theme issue:

Longitudinal and Cohort Studies in Public Health (309) Pharmacovigilance (134) Adverse Drug Events Detection, Pharmacovigilance and Surveillance (156) Pharmacology and Pharmaceutics (66) Colon and Rectal Cancer (21)

Published on in Vol 9 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/50110, first published .
Pharmaceutical Agents as Potential Drivers in the Development of Early-Onset Colorectal Cancer: Case-Control Study

Pharmaceutical Agents as Potential Drivers in the Development of Early-Onset Colorectal Cancer: Case-Control Study

Pharmaceutical Agents as Potential Drivers in the Development of Early-Onset Colorectal Cancer: Case-Control Study

Authors of this article:

Irit Ben-Aharon1 Author Orcid Image ;   Ran Rotem2 Author Orcid Image ;   Cheli Melzer-Cohen3 Author Orcid Image ;   Gilad Twig4, 5, 6 Author Orcid Image ;   Andrea Cercek7 Author Orcid Image ;   Elizabeth Half1 Author Orcid Image ;   Tal Goshen-Lago1 Author Orcid Image ;   Gabriel Chodik5 Author Orcid Image ;   David Kelsen7, 8 Author Orcid Image
Article Authors Cited by (5) Tweetations (2) Metrics

Journals

  1. Kelsen D, Ben-Aharon I, Gordon N. Identifying genetic loci associated with an increased risk for early-onset colorectal cancer. Annals of Oncology 2024;35(6):483 View
  2. 刘 治. Clinical Research Progress of Early-Onset Colorectal Cancer. Advances in Clinical Medicine 2024;14(08):519 View
  3. Mauri G, Patelli G, Sartore-Bianchi A, Abrignani S, Bodega B, Marsoni S, Costanzo V, Bachi A, Siena S, Bardelli A. Early-onset cancers: Biological bases and clinical implications. Cell Reports Medicine 2024;5(9):101737 View
  4. Kane K, Jensen C, Yang J, Dong H, Merchant S, Koripella P, Li X, Hendel J, Corley D, Lee J. Oral Antibiotic Use in Adulthood and Risk of Early-Onset Colorectal Cancer: A Case-Control Study. Clinical Gastroenterology and Hepatology 2024 View
  5. Ben-Aharon I, Smyth E, Wagner A. Dedicated centres and multinational platforms to improve patient care and address early-onset cancers. Nature Reviews Cancer 2024 View